The 'Birmingham Hypertension Square' for the optimum choice of add-in drugs in the management of resistant hypertension

J Hum Hypertens. 1998 Nov;12(11):761-3. doi: 10.1038/sj.jhh.1000688.
No abstract available

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Antihypertensive Agents / therapeutic use*
  • Benzothiadiazines
  • Calcium Channel Blockers / therapeutic use
  • Diuretics
  • Drug Therapy, Combination
  • Humans
  • Hypertension / drug therapy*
  • Models, Theoretical
  • Sodium Chloride Symporter Inhibitors / therapeutic use

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Benzothiadiazines
  • Calcium Channel Blockers
  • Diuretics
  • Sodium Chloride Symporter Inhibitors